Literature DB >> 24863496

Antimicrobial consumption and resistance in five Gram-negative bacterial species in a hospital from 2003 to 2011.

Heng-Sim Lee1, Yue-Xia Loh1, Jen-Jain Lee2, Chang-Shee Liu2, Chishih Chu3.   

Abstract

BACKGROUND: The misuse of antimicrobial agents increases drug resistance in bacteria.
METHODS: The correlation between antimicrobial agent consumption and related resistance in the Gram-negative bacteria Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis was analyzed during the period 2003-2011.
RESULTS: Among these five bacteria, overall E. coli and K. pneumoniae were more commonly isolated from bloodstream than the other species. Regarding Enterobacteriaceae, E. coli and K. pneumoniae showed annual increases of resistance to the tested antimicrobial agents; conversely, P. mirabilis exhibited reduced resistance to cefuroxime, ceftriaxone and cefepime. In contrast to the relatively low antimicrobial resistance in P. aeruginosa, A. baumannii revealed high resistance, which was over 85% resistant rate to the tested antimicrobial agents and over 80% carbapenem resistance in 2011. E. coli, K. pneumoniae, and P. mirabilis differed in development of antimicrobial resistance after consumption of the antimicrobial agents. K. pneumoniae developed resistance to all antimicrobial groups, whereas resistance in P. mirabilis was not related to any antimicrobial consumption. P. aeruginosa developed resistance to β-lactam antimicrobials and aminoglycosides, whereas A. baumanii developed resistance to carbapenems after their use.
CONCLUSION: The development of antimicrobial resistance was related to antimicrobial agents and bacterial species.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Gram-negative bacteria; antimicrobial agents; carbapenem

Mesh:

Substances:

Year:  2014        PMID: 24863496     DOI: 10.1016/j.jmii.2014.04.009

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

1.  Reserve drug indent form and its impact on antimicrobial consumption and sensitivity pattern in the medical intensive care unit of a tertiary care hospital.

Authors:  Deepthi P Shridhar; K B Anitha; Mohandas Rai; Anisha Fernandes
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.

Authors:  Naoki Kohira; Joshua West; Akinobu Ito; Tsukasa Ito-Horiyama; Rio Nakamura; Takafumi Sato; Stephen Rittenhouse; Masakatsu Tsuji; Yoshinori Yamano
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

Review 3.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30

4.  Differences in antimicrobial consumption, prescribing and isolation rate of multidrug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii on surgical and medical wards.

Authors:  Vladimir Zivanovic; Ljiljana Gojkovic-Bukarica; Radisav Scepanovic; Teodora Vitorovic; Radmila Novakovic; Nenad Milanov; Zoran Bukumiric; Biljana Carevic; Jasmina Trajkovic; Jovana Rajkovic; Vladimir Djokic
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

Review 5.  Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections.

Authors:  Eric Wenzler; Debra A Goff; Romney Humphries; Ellie J C Goldstein
Journal:  Infect Dis Ther       Date:  2017-03-04

6.  Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study.

Authors:  Andreas Kronenberg; Jonas Marschall; Alexia Cusini; David Herren; Lukas Bütikofer; Catherine Plüss-Suard
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-28       Impact factor: 4.887

7.  Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016.

Authors:  Chun-Hsing Liao; Na-Yao Lee; Hung-Jen Tang; Susan Shin-Jung Lee; Chin-Fu Lin; Po-Liang Lu; Jiunn-Jong Wu; Wen-Chien Ko; Wen-Sen Lee; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2019-03-04       Impact factor: 4.003

8.  Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients.

Authors:  Stéphanie Druge; Stéphanie Ruiz; Fanny Vardon-Bounes; Marion Grare; François Labaste; Thierry Seguin; Olivier Fourcade; Vincent Minville; Jean-Marie Conil; Bernard Georges
Journal:  J Intensive Care       Date:  2019-07-19

9.  The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacter baumannii.

Authors:  Rima Moghnieh; Hani Tamim; Marwa Jadayel; Dania Abdallah; Rasha Al-Kassem; Hind Kadiri; Hani Hafez; Salam Al-Hassan; Lina Ajjour; Rawad Lakkis; Tamima Jisr; Nadia-Lara Samaha; Nicholas Haddad
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-14       Impact factor: 4.887

10.  Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.

Authors:  Ping Yang; Yunbo Chen; Saiping Jiang; Ping Shen; Xiaoyang Lu; Yonghong Xiao
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.